RheumaGen is developing a breakthrough gene editing treatment that has the potential to cure Rheumatoid Arthritis.
Location: United States, Colorado
Total raised: $15M
Investors 1
| Date | Name | Website |
| 17.05.2024 | SPRIM Glob... | sprim.net |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.01.2025 | Series A | $15M | - |
Mentions in press and media 5
| Date | Title | Description |
| 13.01.2025 | RheumaGen's $15 Million Leap: A New Dawn for Autoimmune Treatment | RheumaGen, a beacon of hope in the world of autoimmune disease treatment, has successfully raised $15 million in Series A funding. This Aurora, Colorado-based company is not just another player in the biotech arena; it’s a pioneer aiming to... |
| 11.01.2025 | RheumaGen: Gene Therapy Company Raises $15 Million (Series A) | RheumaGen – a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases – announced the closing of a $15 million Series A financing co-led by SPRIM Global Investments and William Taylor Nominees. Th... |
| 10.01.2025 | RheumaGen Raises $15M in Series A Funding | RheumaGen, an Aurora, CO-based cell and gene therapy company, raised $15M in Series A funding. The round was led by SPRIM Global Investments and William Taylor Nominees. The company intends to use the funds to support the Phase I clinical t... |
| 09.01.2025 | RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases | Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401, in development for treatment-resistant or refractory rheumatoid arthritis (RA), as a one-time, curative treatment AURORA, CO, Janua... |
| - | RheumaGen | “RheumaGen” |